|
RPE expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.131690E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.174200E-02 |
| Normal-vs-Stage2 |
6.788100E-02 |
| Normal-vs-Stage3 |
3.977400E-03 |
| Normal-vs-Stage4 |
1.017720E-02 |
| Stage1-vs-Stage2 |
5.069000E-01 |
| Stage1-vs-Stage3 |
1.005420E-01 |
| Stage1-vs-Stage4 |
2.074400E-01 |
| Stage2-vs-Stage3 |
6.246000E-01 |
| Stage2-vs-Stage4 |
6.575000E-01 |
| Stage3-vs-Stage4 |
9.953200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.343400E-03 |
| Normal-vs-AfricanAmerican |
7.574800E-01 |
| Normal-vs-Asian |
1.246840E-01 |
| Caucasian-vs-AfricanAmerican |
1.622400E-01 |
| Caucasian-vs-Asian |
6.054000E-01 |
| AfricanAmerican-vs-Asian |
3.736600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.258100E-03 |
| Normal-vs-Female |
3.528000E-02 |
| Male-vs-Female |
1.005250E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.118430E-01 |
| Normal-vs-Age(41-60Yrs) |
1.337790E-02 |
| Normal-vs-Age(61-80Yrs) |
2.351900E-02 |
| Normal-vs-Age(81-100Yrs) |
4.111700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.927630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.812400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.784000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.848000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.541000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.803600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.595200E-01 |
| Classical-VS-Follicular |
8.361000E-01 |
| Classical-VS-Other |
6.018600E-01 |
| Classical-VS-Normal |
5.396300E-02 |
| Tall-VS-Follicular |
5.029400E-01 |
| Tall-VS-Other |
4.164600E-01 |
| Tall-VS-Normal |
3.709000E-01 |
| Follicular-VS-Other |
7.398800E-01 |
| Follicular-VS-Normal |
8.681900E-02 |
| Other-VS-Normal |
1.753210E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.196700E-03 |
| Normal-vs-N1 |
2.288300E-02 |
| N0-vs-N1 |
6.905000E-01 |
|
|
